The effect of Bortezomib and Rapamycin on Telomerase Activity in Mantle Cell Lymphoma

Mantle cell lymphoma (MCL) is a hematological malignancy with unfavorable prognosis. Novel therapeutic approaches for treating the disease are aimed at the mechanisms regulating growth signals, cellular proliferation, and survival pathways of the malignant clones. Bortezomib (Brt), a proteasome inhi...

Descripción completa

Detalles Bibliográficos
Autores principales: Uziel, Orit, Cohen, Olga, Beery, Einat, Nordenberg, Jardena, Lahav, Meir
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2014
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4311042/
https://www.ncbi.nlm.nih.gov/pubmed/25500084
http://dx.doi.org/10.1016/j.tranon.2014.09.004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4311042/
https://www.ncbi.nlm.nih.gov/pubmed/25500084
http://dx.doi.org/10.1016/j.tranon.2014.09.004

Ejemplares similares